SEC Form D private-offering filing

IsoBio, Inc.

A new SEC Form D private-offering notice from Gladwyne, PA, a $3,000,000 filer-stated offering target in Biotech. The source filing is one click away.

IsoBio, Inc. Verified via SEC Form D

Develops antibody-isotope conjugates, radiolabeled antibody therapeutics using isotopes such as Lutetium-177 and Actinium-225, for cancer treatment.

Filed 2025-11-14Filed to raise $3,000,000First money in 2025-10-21Raised so far $1,722,498HQ (as filed) Gladwyne, PASector Biotech ✓Stage (inferred) SeedCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 3 executives & directors
Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.